Skin and Connective Tissue Diseases

445 trials 165 recruiting

Filter these 445 trials by phase, country and sponsor.

Open in Search →

Proactive TDM versus standard use of biologics in psoriasis (HELIOS) Recruiting

2023-509637-39-00 moderate-to-severe psoriasis 6 2024-11-28
Evolution of the initial distribution volume of glucose in the severe burned adults Recruiting

2024-513874-23-00 Severe burns 4 2024-11-27
Clinical trial with adipose tissue stem cells for the treatment of hidradenitis suppurativa. Recruiting

2024-516595-15-00 Hidradenitis suppurativa 9 2024-11-11
Comparison of a personalized maintenance therapy based on the evolution of anti-desmoglein antibodies as biomarkers of pemphigus subclinical… Recruiting

2024-514886-21-00 Pemphigus diseases (Pemphigus Vulgaris - PV and Pemphig 6 2024-11-06
MANUS trial Recruiting

2024-515387-31-00 Systemic Sclerosis 4 2024-11-01
A Long-term Extension Study of Guselkumab in Pediatric Participants Recruiting

2023-509560-16-00 Juvenile psoriatic arthritis (jPsA) 5 2024-10-29
Controlled and randomized clinical trial of the use of plasma rich in growth factors (PRGF) in the treatment of foot ulcers in diabetic pati… Recruiting

2023-504275-24-01 Foot ulcers in diabetic patients with peripheral arteri 6 2024-10-24
NeoLIPA: Neoadjuvant LTX-315 in combination with pembrolizumab in resectable stage III/IV melanoma Recruiting

2023-508649-42-00 Patients with clinically detectable and resectable stag 4 2024-10-23
Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting

2024-511719-40-00 Enterococcus faecalis infectious endocarditis 6 2024-10-09
NOVEL TREATMENT OF DIABETIC FOOT ULCER BY AUTOLOGOUS STROMAL VASCULAR FRACTION OF ADIPOSE TISSUE Recruiting

2024-516342-19-00 Diabetic Foot ulcERs 4 2024-09-13
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Adaptive Phase 3 Study to Evaluate the Efficacy and Safety of Sinecatechins (De… Recruiting

2022-502811-12-00 Actinic Keratosis (AK) of the Scalp and/or the Face. 5 2024-09-04
DICIT: Efficacy of diclofenac added to an approved, ongoing PD-1 inhibitor therapy that achieved stable disease as best response in metastat… Recruiting

2023-504191-26-00 Metastatic Melanoma 10 2024-08-23
A Phase 2 clinical study to assess efficacy of induction carboplatin/paclitaxel + pembrolizumab for locoregionally advanced penile cancer: P… Recruiting

2023-506731-15-00 locoregionally advanced penile cancer 4 2024-08-13
MB-CART19.1 in refractory SLE Recruiting

2023-507654-33-00 Refractory systemic lupus erythematosus (SLE) 9 2024-08-12
Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery. Recruiting

2024-515235-29-00 Reconstructive skin surgery in basal cell cancer (Mohs 4 2024-07-09
Calcinosis cutis in SSc patients treated with sodium thiosulfate assessed by biomarkers and imaging Recruiting

2023-510255-34-00 Calcinosis cutis in systemic sclerosis 6 2024-06-21
Treatment of difficult-to-heal wounds with stem cells included in a gel consistency dressing Recruiting

2023-505017-25-02 Hard-to-heal-wounds 7 2024-06-10
A study of the efficacy and safety of belimumab compared to placebo in adults with systemic sclerosis-associated interstitial lung disease. Recruiting

2023-503219-14-01 systemic sclerosis associated interstitial lung disease 10 2024-05-22
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study with Open-Label Extension Evalu… Recruiting

2023-508818-42-00 Generalized Epidermolysis Bullosa Simplex (EBS) 10 2024-05-21
Evaluation of the efficacy and safety of a new gel containing 10 mg/g Clindamycin and 0.25 mg/g Tretinoin vs. the originator Acnatac(R) 10 m… Recruiting

2023-504552-10-01 Papulopustular acne 5 2024-05-14
Long-Term Follow-up of Patients Treated with Miltenyi Cell and Gene Therapies Recruiting

2022-501648-14-00 Relapsed or refractory CD19 positive B cell malignancie 9 2024-05-05
UVB: treatment of UVeitis in Behçet’s diseases with biologic Recruiting

2024-513371-41-00 Severe uveitis of Behçet’s disease 4 2024-04-25
Mesenchymal stromal cells treatment in Lyell syndrome: A pilot phase 1-2 open trial (LYSYME) Recruiting

2024-516404-42-00 Adults diagnosed with SJS-TEN with at least 10% of body 9 2024-04-15
GENEPID: A 44-weeks monocentric open study assessing the efficacy and safety of Deucravacitinib in adults with Inflammatory EPidermal GENode… Recruiting

2022-502879-32-00 Inflammatory EPidermal GENodermatoses 4 2024-01-30